PREV — Preveceutical Medical Balance Sheet
0.000.00%
- CA$20.54m
- CA$25.13m
Annual balance sheet for Preveceutical Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.156 | 0.016 | 0.006 | 0.001 | 0.059 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.091 | 0.055 | 0.019 | 0.005 | 0.027 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.263 | 0.083 | 0.063 | 0.064 | 0.117 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.009 | 0.002 | 0.001 | 0.001 | 0.002 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.302 | 0.161 | 0.189 | 0.182 | 0.226 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.03 | 2.59 | 4.82 | 5.96 | 6.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 3.91 | 4.27 | 4.82 | 5.96 | 6.86 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | -3.6 | -4.1 | -4.64 | -5.78 | -6.64 |
| Total Liabilities & Shareholders' Equity | 0.302 | 0.161 | 0.189 | 0.182 | 0.226 |
| Total Common Shares Outstanding |